{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:47:31Z","timestamp":1789343251931,"version":"build-2803163510"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T00:00:00Z","timestamp":1288742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1749-8090-5-101","type":"journal-article","created":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T19:30:14Z","timestamp":1288812614000},"source":"Crossref","is-referenced-by-count":76,"title":["Antiphospholipid syndrome; its implication in cardiovascular diseases: a review"],"prefix":"10.1186","volume":"5","author":[{"given":"Ioanna","family":"Koniari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros N.","family":"Siminelakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos G.","family":"Baikoussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Goudevenos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Apostolakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,3]]},"reference":[{"key":"333_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RHWM, DeGroot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4: 295-306. 10.1111\/j.1538-7836.2006.01753.x.","journal-title":"J Thromb Haemost"},{"key":"333_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejcts.2007.11.004","volume":"33","author":"H Gorki","year":"2008","unstructured":"Gorki H, Malinovski V, Stanbridge RDL: The antiphospholipid syndrome and heart valve surgery. Eur J CardioThorac Surg. 2008, 33: 168-18. 10.1016\/j.ejcts.2007.11.004.","journal-title":"Eur J CardioThorac Surg"},{"key":"333_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1046\/j.1365-2141.2001.03178.x","volume":"115","author":"A Tripodi","year":"2001","unstructured":"Tripodi A, Chantarangkul V, Clerici M, Negri B, Galli M, Mannucci PM: Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. Br J Haematol. 2001, 115: 672-8. 10.1046\/j.1365-2141.2001.03178.x.","journal-title":"Br J Haematol"},{"key":"333_CR4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/096120339600500516","volume":"5","author":"RA Asherson","year":"1996","unstructured":"Asherson RA, Piette JC: The catastrophic antiphospholipid syndrome: acute multiorgan failure associated with antiphospholipid antibodies: a review of 31 patients. Lupus. 1996, 5: 414-7.","journal-title":"Lupus"},{"key":"333_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.hlc.2007.03.010","volume":"16","author":"VAP Hedge","year":"2007","unstructured":"Hedge VAP, Vivas Y, Shah H, Haybron D, Srinivasan V, Dua A, Gradman A: Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome- a case series. Heart, Lung and Circulation. 2007, 16: 423-427. 10.1016\/j.hlc.2007.03.010.","journal-title":"Heart, Lung and Circulation"},{"key":"333_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1536\/ihj.46.631","volume":"46","author":"A Gurlek","year":"2005","unstructured":"Gurlek A, Ozdol C, Pamir G: Association Between Anticardiolipin Antibodies and Recurrent Cardiac Events in Patients With Acute Coronary Syndrome. Int Heart J. 2005, 46: 631-638. 10.1536\/ihj.46.631.","journal-title":"Int Heart J"},{"key":"333_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1191\/096120300678828532","volume":"9","author":"M Turiel","year":"2000","unstructured":"Turiel M, Muzzupappa S, Gottardi B: Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography. Lupus. 2000, 9: 406-12. 10.1191\/096120300678828532.","journal-title":"Lupus"},{"key":"333_CR8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1053\/j.jvca.2008.01.021","volume":"22","author":"S Weiss","year":"2008","unstructured":"Weiss S, Nyzio JB, Cines D, Detre J, Milas BL, Narula N, Floyd TF: Antiphospholipid syndrome : Intraoperative and postoperative anticoagulation in cardiac surgery. J Cardiothorac Vasc Anesth. 2008, 22: 735-9. 10.1053\/j.jvca.2008.01.021.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"333_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1046\/j.1365-2141.2000.02069.x","volume":"109","author":"M Greaves","year":"2000","unstructured":"Greaves M, Cohen H, MacHin SJ, Mackie I: Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol. 2000, 109: 704-15. 10.1046\/j.1365-2141.2000.02069.x.","journal-title":"Br J Haematol"},{"key":"333_CR10","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","volume":"102","author":"M Galli","year":"2003","unstructured":"Galli M, Luciani D, Bertolini G, Barbui T: Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood. 2003, 102: 2717-23. 10.1182\/blood-2002-11-3334.","journal-title":"Blood"},{"key":"333_CR11","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood.V81.10.2618.2618","volume":"81","author":"JD Oosting","year":"1993","unstructured":"Oosting JD, Derksen RH, Bobbink IW, Hackeng TM, Bouma BN, deGroot PG: Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?. Blood. 1993, 81: 2618-25.","journal-title":"Blood"},{"key":"333_CR12","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","volume":"335","author":"M Galli","year":"1990","unstructured":"Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, Barbui T, Zwaal RF, Bevers EM: Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990, 335: 1544-7. 10.1016\/0140-6736(90)91374-J.","journal-title":"Lancet"},{"key":"333_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/01.RES.88.2.245","volume":"88","author":"SS Pierangeli","year":"2001","unstructured":"Pierangeli SS, Espinola RG, Liu X, Harris EN: Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ Res. 2001, 88: 245-50.","journal-title":"Circ Res"},{"key":"333_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/jaut.2000.0397","volume":"15","author":"RA Roubey","year":"2000","unstructured":"Roubey RA: Tissue factor pathway and the antiphospholipid syndrome. Autoimmunol. 2000, 15: 217-20. 10.1006\/jaut.2000.0397.","journal-title":"Autoimmunol"},{"key":"333_CR15","doi-asserted-by":"publisher","first-page":"33831","DOI":"10.1074\/jbc.M212655200","volume":"278","author":"BCH Lutters","year":"2003","unstructured":"Lutters BCH, Derksen RHWM, Tekelenburg WL, Lenting PJ, Arnout J, deGroot PG: Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'. J Biol Chem. 2003, 278: 33831-8. 10.1074\/jbc.M212655200.","journal-title":"J Biol Chem"},{"key":"333_CR16","doi-asserted-by":"publisher","first-page":"15541","DOI":"10.1074\/jbc.275.20.15541","volume":"275","author":"K Ma","year":"2000","unstructured":"Ma K, Simantov R, Zhang JC, Silverstein R, Hajjar KA, McCrae KR: High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem. 2000, 275: 15541-8. 10.1074\/jbc.275.20.15541.","journal-title":"J Biol Chem"},{"key":"333_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-2249.2004.02497.x","volume":"136","author":"CG Mackworth-Young","year":"2004","unstructured":"Mackworth-Young CG: Antiphospholipid syndrome: Multiple mechanisms. Clin Exp Immunol. 2004, 136: 393-401. 10.1111\/j.1365-2249.2004.02497.x.","journal-title":"Clin Exp Immunol"},{"key":"333_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/bja\/aeh116","volume":"92","author":"RI Dornan","year":"2004","unstructured":"Dornan RI: Acute postoperative biventricular failure associated with antiphospholipid antibody syndrome. Br J Anaesth. 2004, 92: 748-54. 10.1093\/bja\/aeh116.","journal-title":"Br J Anaesth"},{"key":"333_CR19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","volume":"112","author":"PE Love","year":"1990","unstructured":"Love PE, Santaro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med. 1990, 112: 682-98.","journal-title":"Ann Intern Med"},{"key":"333_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0167-5699(90)90020-A","volume":"11","author":"C Mackworth-Young","year":"1990","unstructured":"Mackworth-Young C: Antiphospholipin antibodies: more than just a disease marker?. Immunol Today. 1990, 11: 60-5. 10.1016\/0167-5699(90)90020-A.","journal-title":"Immunol Today"},{"key":"333_CR21","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood.V92.5.1652","volume":"92","author":"JH Rand","year":"1998","unstructured":"Rand JH, Wu XX, Andree HAM: Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a \"lupus procoagulant\" phenomenon. Blood. 1998, 92: 1652-60.","journal-title":"Blood"},{"key":"333_CR22","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/00000539-200005000-00017","volume":"90","author":"Chr East","year":"2000","unstructured":"East Chr, Clements F, Mathew J: Antiphospholipid Syndrome and Cardiac Surgery: Management of anticoagulation in two Patients. Anesth Analg. 2000, 90: 1098-101. 10.1097\/00000539-200005000-00017.","journal-title":"Anesth Analg"},{"key":"333_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.thromres.2004.06.045","volume":"114","author":"PL Meroni","year":"2004","unstructured":"Meroni PL, Borghi MO, Raschi E: Inflammatory response and the endothelium. Thromb Res. 2004, 114: 329-334. 10.1016\/j.thromres.2004.06.045.","journal-title":"Thromb Res"},{"key":"333_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/jaut.2000.0405","volume":"15","author":"R Cervera","year":"2000","unstructured":"Cervera R: Recent advances in antiphospholipid antibodyrelated valvulopathies. J Autoimmun. 2000, 15: 123-5. 10.1006\/jaut.2000.0405.","journal-title":"J Autoimmun"},{"key":"333_CR25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/01.STR.0000154858.27353.df","volume":"36","author":"D Erdogan","year":"2005","unstructured":"Erdogan D, Goren MT, Diz-Kucukkaya R: Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: A transesophageal echocardiographic study. Stroke. 2005, 36: 592-596. 10.1161\/01.STR.0000154858.27353.df.","journal-title":"Stroke"},{"key":"333_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF03217739","volume":"46","author":"G Sakaguchi","year":"1998","unstructured":"Sakaguchi G, Minami K, Nakayama S: Aortic valve replacement after previous coronary artery bypass grafting in a patient with antiphospholipid syndrome. Jpn J Thorac Cardiovasc Surg. 1998, 46: 257-9.","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"333_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1055\/s-2008-1055410","volume":"120","author":"M Schumacher","year":"1995","unstructured":"Schumacher M, Eber B, Dusleag J, Fruhwald FM, Zweiker R, Pokan R, Klein W: Thrombosis of a prosthetic mitral valve in the anticardiolipin syndrome. Dtsch Med Wochenschr. 1995, 120: 795-8. 10.1055\/s-2008-1055410.","journal-title":"Dtsch Med Wochenschr"},{"key":"333_CR28","doi-asserted-by":"publisher","first-page":"971","DOI":"10.4065\/75.9.971","volume":"75","author":"WJ Hogan","year":"2000","unstructured":"Hogan WJ, McBane RD, Santrach PJ, Plumhoff EA, Oliver WC, Schaff HV, Rodeheffer RJ, Edwards WD, Duffy J, Nichols WL: Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery. Mayo Clin Proc. 2000, 75: 971-6. 10.4065\/75.9.971.","journal-title":"Mayo Clin Proc"},{"key":"333_CR29","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMra002974","volume":"346","author":"JS Levine","year":"2002","unstructured":"Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med. 2002, 346: 752-63. 10.1056\/NEJMra002974.","journal-title":"N Engl J Med"},{"key":"333_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s005950050155","volume":"28","author":"M Nakayama","year":"1998","unstructured":"Nakayama M, Kumon K, Yahagi N: Antiphospholipid antibody syndrome in a case with redo coronary artery bypass grafting under cardiopulmonary bypass. Surg Today. 1998, 28: 423-426. 10.1007\/s005950050155.","journal-title":"Surg Today"},{"key":"333_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0002-9610(99)80285-2","volume":"170","author":"RG Ciocca","year":"1995","unstructured":"Ciocca RG, Choi J, Graham AM: Antiphospholipid antibodies lead to increased risk in cardiovascular surgery. Am J Surg. 1995, 170: 198-200. 10.1016\/S0002-9610(99)80285-2.","journal-title":"Am J Surg"},{"key":"333_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2796.1993.tb00990.x","volume":"233","author":"P Jorgensen","year":"1993","unstructured":"Jorgensen P, Hansen PR: Antiphospholipid antibodies and ischaemic heart disease. J Intern Med. 1993, 233: 291-293. 10.1111\/j.1365-2796.1993.tb00990.x.","journal-title":"J Intern Med"},{"key":"333_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/qjmed\/93.8.523","volume":"93","author":"MG Tektonidou","year":"2000","unstructured":"Tektonidou MG, Ionnidis JPA, Boki KA, Vlachoyiannopoulos PG, Moutsopoulos HM: Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome. Q J Med. 2000, 93: 523-30.","journal-title":"Q J Med"},{"issue":"Suppl 13","key":"333_CR34","first-page":"208","volume":"14","author":"EN Harris","year":"1987","unstructured":"Harris EN, Hughes GR, Gharav AE: Antiphospholipid antibodies: an elderly statesman dons new garments. J Rheumatol. 1987, 14 (Suppl 13): 208-13.","journal-title":"J Rheumatol"},{"key":"333_CR35","first-page":"263","volume":"6","author":"SS Shapiro","year":"1982","unstructured":"Shapiro SS, Thiagarajan P: Lupus anticoagulants. Prog Hemost Thromb. 1982, 6: 263-85.","journal-title":"Prog Hemost Thromb"},{"issue":"4","key":"333_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1177\/0961203309360545","volume":"19","author":"D Erkan","year":"2010","unstructured":"Erkan D, Lockshin : Non-criteria manifestations of antiphospholipid syndrome. Lupus. 2010, 19 (4): 424-7. 10.1177\/0961203309360545.","journal-title":"Lupus"},{"key":"333_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","volume":"80","author":"RA Asherson","year":"2001","unstructured":"Asherson RA, Cervera R, Piette JC, Shoenfeld Y, Espinosa G, Petri MA, Lim E, Lau TC, Gurjal A, Jedryka-G\u00f3ral A, Chwalinska-Sadowska H, Dibner RJ, Rojas-Rodr\u00edguez J, Garc\u00eda-Carrasco M, Grandone JT, Parke AL, Barbosa P, Vasconcelos C, Ramos-Casals M, Font J, Ingelmo M: Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Med Baltim. 2001, 80: 355-77. 10.1097\/00005792-200111000-00002.","journal-title":"Med Baltim"},{"key":"333_CR38","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1046\/j.1365-2141.2000.02069.x","volume":"109","author":"M Greaves","year":"2000","unstructured":"Greaves M, Cohen H, MacHin SJ, Mackie I: Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol. 2000, 109: 704-15. 10.1046\/j.1365-2141.2000.02069.x.","journal-title":"Br J Haematol"},{"issue":"Suppl I","key":"333_CR39","first-page":"11","volume":"23","author":"DA Triplett","year":"1992","unstructured":"Triplett DA: Coagulation assays for the lupus anticoagulant: review and critique of current methodology. Stroke. 1992, 23 (Suppl I): 11-4.","journal-title":"Stroke"},{"key":"333_CR40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/clinchem\/43.7.1105","volume":"43","author":"C Eby","year":"1997","unstructured":"Eby C: Standardization of APTTreagents for heparin therapy monitoring: urgent or fading priority?. Clin Chem. 1997, 43: 1105-7.","journal-title":"Clin Chem"},{"key":"333_CR41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1055\/s-0038-1650356","volume":"75","author":"J Arvieux","year":"1996","unstructured":"Arvieux J, Darnige L, Hachulla E, Roussel B, Bensa JC, Coulomb MG: Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation. Thromb Haemost. 1996, 75: 725-30.","journal-title":"Thromb Haemost"},{"key":"333_CR42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1160\/TH04-06-0382","volume":"93","author":"ML Bertolaccini","year":"2005","unstructured":"Bertolaccini ML, Atsumi T, Koike T, Hughes GRV, Khamashta MA: Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost. 2005, 93: 289-97.","journal-title":"Thromb Haemost"},{"key":"333_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0140-6736(93)91477-4","volume":"342","author":"GR Hughes","year":"1993","unstructured":"Hughes GR: The antiphospholipid syndrome: ten years on. Lancet. 1993, 342: 341-4. 10.1016\/0140-6736(93)91477-4.","journal-title":"Lancet"},{"key":"333_CR44","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/BF01660956","volume":"68","author":"B Eber","year":"1990","unstructured":"Eber B, Kronberger-Schaffer E, Brusee H: Anticardiolipin antibodies are no marker for survived myocardial infarction. Klin Wochenschr. 1990, 68: 594-6. 10.1007\/BF01660956.","journal-title":"Klin Wochenschr"},{"key":"333_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/08916939809003861","volume":"27","author":"C Ludia","year":"1998","unstructured":"Ludia C, Domenico P, Monia C: Antiphospholipid antibodies: a new risk factor for restenosis after percutaneous transluminal coronary angioplasty?. Autoimmunity. 1998, 27: 141-8. 10.3109\/08916939809003861.","journal-title":"Autoimmunity"},{"key":"333_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0021-9150(00)00439-1","volume":"154","author":"L Chiarugi","year":"2001","unstructured":"Chiarugi L, Prisco D, Antonucci E: Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restosis after elective balloon precutaneus transluminal coronary angioplasty. Atherosclerosis. 2001, 154: 129-35. 10.1016\/S0021-9150(00)00439-1.","journal-title":"Atherosclerosis"},{"issue":"3","key":"333_CR47","first-page":"288","volume":"52","author":"S Sharma","year":"2008","unstructured":"Sharma S, Malhotra A, Sharma YP, Pandhi P, Malhotra S, Nageswari KS, Shafiq N, Venkateshan SP, Kaur R: Association of anticardiolipin antibodies levels with instent restenosis in patients with coronary artery disease. Indian J Physiol Pharmacol. 2008, 52 (3): 288-92.","journal-title":"Indian J Physiol Pharmacol"},{"key":"333_CR48","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1161\/01.CIR.102.11.1258","volume":"102","author":"A Bili","year":"2000","unstructured":"Bili A, Moss AJ, Francis CW, Zareba W, Watelet LF, Sanz I: Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Invertigators. Circulation. 2000, 102: 1258-63.","journal-title":"Circulation"},{"key":"333_CR49","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0002-9343(96)00226-4","volume":"104","author":"E Zuckerman","year":"1996","unstructured":"Zuckerman E, Toubi E, Shiran A: Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythematosus patients: a controlled prospective study. Am J Med. 1996, 104: 381-6. 10.1016\/S0002-9343(96)00226-4.","journal-title":"Am J Med"},{"key":"333_CR50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0140-6736(86)92258-0","volume":"1","author":"R Hamsten Ai Norberg","year":"1986","unstructured":"Hamsten Ai Norberg R, Bjorkholm M, de Faire U, Holm G: Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet. 1986, 1: 113-6. 10.1016\/S0140-6736(86)92258-0.","journal-title":"Lancet"},{"key":"333_CR51","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0140-6736(92)91057-F","volume":"339","author":"KE Sletnes","year":"1992","unstructured":"Sletnes KE, Smith P, Abdelnoor N, Arnesen H, Wisloff F: Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-hemorrhagic stroke. Lancet. 1992, 339: 451-3. 10.1016\/0140-6736(92)91057-F.","journal-title":"Lancet"},{"key":"333_CR52","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/0140-6736(92)90966-7","volume":"339","author":"M Cortellaro","year":"1992","unstructured":"Cortellaro M, Boschetti C, Cardillo M, Barbui T: Antiphospholipid antibodies in patients with previous myocardial infaction. Lancet. 1992, 339: 929-30. 10.1016\/0140-6736(92)90966-7.","journal-title":"Lancet"},{"key":"333_CR53","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/hrt.69.5.391","volume":"69","author":"KV Phadke","year":"1993","unstructured":"Phadke KV, Phillips RA, Clarke DT, Jones M, Naish P, Carson P: Anticardiolipin antibodies in ischemic heart disease: marker or myth?. Br Heart J. 1993, 69: 391-4. 10.1136\/hrt.69.5.391.","journal-title":"Br Heart J"},{"key":"333_CR54","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1182\/asheducation-2003.1.497","volume":"1","author":"TE Warkentin","year":"2003","unstructured":"Warkentin TE, Aird WC, Rand JH: Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome. Hematology. 2003, 1: 497-519. 10.1182\/asheducation-2003.1.497.","journal-title":"Hematology"},{"key":"333_CR55","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jtcvs.2003.07.016","volume":"127","author":"Y Berkun","year":"2004","unstructured":"Berkun Y, Elami A, Meir K: Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg. 2004, 127: 414-420. 10.1016\/j.jtcvs.2003.07.016.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"333_CR56","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1540-8191.2007.00351.x","volume":"22","author":"K Leissner","year":"2007","unstructured":"Leissner K, Ketchedjian A, Crowley R: Deep hypothermic circulatory arrest and Bivalirudin use in a patient with heparin-induced thrombocytopenia and antiphospholipid syndrome. J Card Surg. 2007, 22: 78-82. 10.1111\/j.1540-8191.2007.00351.x.","journal-title":"J Card Surg"},{"key":"333_CR57","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0889-8537(03)00042-7","volume":"21","author":"JA Green","year":"2003","unstructured":"Green JA, Spiess BD: Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest. Anesthesiol Clin North America. 2003, 21: 527-551. 10.1016\/S0889-8537(03)00042-7.","journal-title":"Anesthesiol Clin North America"},{"key":"333_CR58","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0022-5223(05)80008-X","volume":"110","author":"GJ Despotis","year":"1995","unstructured":"Despotis GJ, Joist JH, Hogue CW: The impact of heparin concentration and cativated clotting time monitoring on blood conservation. J Thorac Cardiovasc Surg. 1995, 110: 46-54. 10.1016\/S0022-5223(05)80008-X.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"333_CR59","doi-asserted-by":"publisher","first-page":"971","DOI":"10.4065\/75.9.971","volume":"75","author":"WJ Hogan","year":"2000","unstructured":"Hogan WJ, McBane RD, Santrach PJ: Antiphospholipid syndrome and perioperative haemostatic management of cardiac valvular surgery. Mayo Clin Proc. 2000, 75: 971-6. 10.4065\/75.9.971.","journal-title":"Mayo Clin Proc"},{"key":"333_CR60","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/00000539-200005000-00017","volume":"90","author":"CJ East","year":"2000","unstructured":"East CJ, Clements F, Mathew J, Slaughter TF: Antiphospholipid syndrome and cardiac surgery: management of anticoagulation in two patients. Anesth Analg. 2000, 90: 1098-101. 10.1097\/00000539-200005000-00017.","journal-title":"Anesth Analg"},{"key":"333_CR61","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S1053-0770(97)90173-7","volume":"11","author":"F Shiekh","year":"1997","unstructured":"Shiekh F, Lechowicz A, Setlur R: Recognition and management of patients with antiphospholipid antibody syndrome undergoing cardiac surgery. J Cardiothor Vasc Anesth. 1997, 11: 764-6. 10.1016\/S1053-0770(97)90173-7.","journal-title":"J Cardiothor Vasc Anesth"},{"key":"333_CR62","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJM199504133321504","volume":"332","author":"MA Khamashta","year":"1995","unstructured":"Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV: The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995, 332: 993-7. 10.1056\/NEJM199504133321504.","journal-title":"N Engl J Med"},{"key":"333_CR63","first-page":"1065","volume":"84","author":"P Della Valle","year":"1999","unstructured":"Della Valle P, Crippa L, Garlando A-M: Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in antiphospholipid-antibody syndrome. Haematologica. 1999, 84: 1065-1074.","journal-title":"Haematologica"},{"key":"333_CR64","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/096120339400300205","volume":"3","author":"G Rivier","year":"1994","unstructured":"Rivier G, Herranz MT, Khamashta MA, Hughes GRV: hrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments. Lupus. 1994, 3: 85-90. 10.1177\/096120339400300205.","journal-title":"Lupus"},{"issue":"3","key":"333_CR65","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1055\/s-0028-1082269","volume":"34","author":"RA Asherson","year":"2008","unstructured":"Asherson RA, Cervera R, Merrill JT, Erkan D: Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Semin Thromb Hemost. 2008, 34 (3): 256-66. 10.1055\/s-0028-1082269.","journal-title":"Semin Thromb Hemost"},{"key":"333_CR66","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1056\/NEJM199504133321510","volume":"332","author":"MD Lockshin","year":"1995","unstructured":"Lockshin MD: Answers to the antiphospholipid-antibody syndrome?. N Engl J Med. 1995, 332: 1025-7. 10.1056\/NEJM199504133321510.","journal-title":"N Engl J Med"},{"key":"333_CR67","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S0002-9343(96)00060-5","volume":"100","author":"G Finazzi","year":"1996","unstructured":"Finazzi G, Brancaccio V, Moia M: Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies. A five-year prospective study from the Italian registry. Am J Med. 1996, 100: 530-6. 10.1016\/S0002-9343(96)00060-5.","journal-title":"Am J Med"},{"key":"333_CR68","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.V86.10.3685.bloodjournal86103685","volume":"86","author":"JS Ginsberg","year":"1995","unstructured":"Ginsberg JS, Wells PS, Brill-Edwards P: Antiphospholipid antibodies and venous thromboembolism. Blood. 1995, 86: 3685-91.","journal-title":"Blood"},{"key":"333_CR69","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","volume":"104","author":"S Schulman","year":"1998","unstructured":"Schulman S, Svenungsson E, Granqvist S, The Duration of Anticoagulation Study Group: Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med. 1998, 104: 332-8. 10.1016\/S0002-9343(98)00060-6.","journal-title":"Am J Med"},{"key":"333_CR70","doi-asserted-by":"crossref","unstructured":"Haemostasis and Thrombosis Task Force. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol. 2000, 109: 704-15. 10.1046\/j.1365-2141.2000.02069.x.","DOI":"10.1046\/j.1365-2141.2000.02069.x"},{"key":"333_CR71","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1046\/j.1365-2141.2001.03178.x","volume":"115","author":"A Tripodi","year":"2001","unstructured":"Tripodi A, Chantarangkul V, Clerici M, Negri B, Galli M, Mannucci PM: Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. Br J Haematol. 2001, 115: 672-8. 10.1046\/j.1365-2141.2001.03178.x.","journal-title":"Br J Haematol"},{"key":"333_CR72","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S1053-0770(03)00210-6","volume":"17","author":"G Gordon","year":"2003","unstructured":"Gordon G, Rastegar H, Schumann R: Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. J Cardiothorac Vasc Anesth. 2003, 17: 632-635. 10.1016\/S1053-0770(03)00210-6.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"333_CR73","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/0002-8703(91)90604-G","volume":"122","author":"D Harpaz","year":"1991","unstructured":"Harpaz D, Glikson M, Side Y, Hod H: Successful thrombolytic therapy for acute myocardial infarction in a patient with the antiphospholipid antibody syndrome. Am Heart J. 1991, 122: 1492-4. 10.1016\/0002-8703(91)90604-G.","journal-title":"Am Heart J"},{"key":"333_CR74","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1055\/s-2004-831046","volume":"30","author":"AF Merry","year":"2004","unstructured":"Merry AF: Bivalirudin, blood loss, and graft patency in coronary artery bypass surgery. Semin Thromb Hemost. 2004, 30: 337-346. 10.1055\/s-2004-831046.","journal-title":"Semin Thromb Hemost"},{"key":"333_CR75","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jtcvs.2004.09.016","volume":"129","author":"A Koster","year":"2005","unstructured":"Koster A, Yeter R, Buz S: Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: Results of a pilot study. J Thorac Cardiovasc Surg. 2005, 129: 1391-1394. 10.1016\/j.jtcvs.2004.09.016.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"333_CR76","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/S0003-4975(03)01471-1","volume":"78","author":"SB Clayton","year":"2004","unstructured":"Clayton SB, Acsell JR, Crumbley AJ: cardiopulmonary bypass with bivalirudin in type II heparin- nduced thrombocytopenia. Ann Thorac Surg. 2004, 78: 2167-2169. 10.1016\/S0003-4975(03)01471-1.","journal-title":"Ann Thorac Surg"},{"key":"333_CR77","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.athoracsur.2003.09.061","volume":"77","author":"AF Merry","year":"2004","unstructured":"Merry AF, Raudkivi PJ, Middleton NG: Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surg. 2004, 77: 925-931. 10.1016\/j.athoracsur.2003.09.061.","journal-title":"Ann Thorac Surg"},{"key":"333_CR78","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.healun.2003.11.401","volume":"24","author":"MJ Mann","year":"2005","unstructured":"Mann MJ, Tseng E, Ratcliffe M: Use of bivalirudin, a direct thrombin inhibitor, and its reversal with modified ultrafiltration during heart transplantation in a patient with heparin-induced thrombocytopenia. J Heart Lung Transplant. 2005, 24: 222-225. 10.1016\/j.healun.2003.11.401.","journal-title":"J Heart Lung Transplant"},{"key":"333_CR79","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1055\/s-2004-831044","volume":"30","author":"A Greinacher","year":"2004","unstructured":"Greinacher A: The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia. Semin Thromb Hemost. 2004, 30: 315-327. 10.1055\/s-2004-831044.","journal-title":"Semin Thromb Hemost"},{"key":"333_CR80","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1111\/j.1538-7836.2005.01374.x","volume":"3","author":"JI Weitz","year":"2005","unstructured":"Weitz JI, Bates SM: New anticoagulants. J Thromb Haemost. 2005, 3: 1843-1853. 10.1111\/j.1538-7836.2005.01374.x.","journal-title":"J Thromb Haemost"},{"key":"333_CR81","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.amjcard.2003.10.021","volume":"93","author":"A Koster","year":"2004","unstructured":"Koster A, Spiess B, Chew DP: Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2004, 93: 356-359. 10.1016\/j.amjcard.2003.10.021.","journal-title":"Am J Cardiol"},{"key":"333_CR82","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.athoracsur.2004.08.037","volume":"80","author":"CM Dyke","year":"2005","unstructured":"Dyke CM, Koster A, Veale JJ: Preemptive use of Bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia. Ann Thorac Surg. 2005, 80: 299-303. 10.1016\/j.athoracsur.2004.08.037.","journal-title":"Ann Thorac Surg"},{"key":"333_CR83","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","volume":"80","author":"RA Asherson","year":"2001","unstructured":"Asherson RA, Cervera R, Piette JC: Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine. 2001, 80: 355-77. 10.1097\/00005792-200111000-00002.","journal-title":"Medicine"},{"key":"333_CR84","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","volume":"77","author":"RA Asherson","year":"1998","unstructured":"Asherson RA, Cervera R, Piette JC: Catastrophic antiphospholipid syndrome: Clinical and laboratory features of 50 patients. Medicine. 1998, 77: 195-207. 10.1097\/00005792-199805000-00005.","journal-title":"Medicine"},{"key":"333_CR85","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/01.CIR.84.2.920","volume":"84","author":"R Asherson","year":"1991","unstructured":"Asherson R, Cervera R: Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation. 1991, 84: 920-3.","journal-title":"Circulation"},{"key":"333_CR86","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/bja\/70.5.587","volume":"70","author":"G Menon","year":"1993","unstructured":"Menon G, Allt-Graham J: Anaesthetic implications of the anticardiolipin antibody syndrome. Br J Anaesth. 1993, 70: 587-90. 10.1093\/bja\/70.5.587.","journal-title":"Br J Anaesth"},{"key":"333_CR87","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1136\/bmj.296.6635.1505","volume":"296","author":"JH Brown","year":"1988","unstructured":"Brown JH, Doherty CC, Allen DC, Morton P: Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus. BMJ. 1988, 296: 1505-10.1136\/bmj.296.6635.1505.","journal-title":"BMJ"},{"key":"333_CR88","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1056\/NEJM200003093421003","volume":"342","author":"RE McCarthy","year":"2000","unstructured":"McCarthy RE, Boehmer JP, Hruban RH: Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000, 342: 690-5. 10.1056\/NEJM200003093421003.","journal-title":"N Engl J Med"},{"key":"333_CR89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/hrt.62.1.61","volume":"62","author":"JJ Murphy","year":"1989","unstructured":"Murphy JJ, Leach IA: Findings at necropsy in the heart of a patient with anticardiolipin syndrome. Br Heart J. 1989, 62: 61-4. 10.1136\/hrt.62.1.61.","journal-title":"Br Heart J"},{"key":"333_CR90","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/0310057X0203000219","volume":"30","author":"R Nagappan","year":"2002","unstructured":"Nagappan R, Lodge RS: Acute autoimmune cardiomyopathy in primary antiphospholipid antibody syndrome. Anaesth Intens Care. 2002, 30: 226-9.","journal-title":"Anaesth Intens Care"},{"key":"333_CR91","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00062752-200009000-00011","volume":"7","author":"Y Sherer","year":"2000","unstructured":"Sherer Y, Snoenfeld Y: Antiphospholipid syndrome: insights from animal models. Curr Opin Hematol. 2000, 7: 321-4. 10.1097\/00062752-200009000-00011.","journal-title":"Curr Opin Hematol"},{"key":"333_CR92","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1191\/0961203306lu2315oa","volume":"15","author":"M Vega Ostertag","year":"2006","unstructured":"Vega Ostertag M, Liu X, Henderson V, Pierangeli SS: A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice. Lupus. 2006, 15: 358-65. 10.1191\/0961203306lu2315oa.","journal-title":"Lupus"},{"key":"333_CR93","doi-asserted-by":"crossref","unstructured":"Morton KE, Gavaghan TP, Krilis SA: Coronary artery bypass graft failure -An autoimmune phenomenon?. Lancet. 1986, 1353-6. 10.1016\/S0140-6736(86)92004-0. ii","DOI":"10.1016\/S0140-6736(86)92004-0"},{"key":"333_CR94","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/026765919901400512","volume":"14","author":"G Myers","year":"1999","unstructured":"Myers G, Hirsch G: Double valve replacement in a patient with anticardiolipin antibody syndrome. Perfusion. 1999, 14: 397-401.","journal-title":"Perfusion"},{"key":"333_CR95","first-page":"1042","volume":"85","author":"R Asherson","year":"1995","unstructured":"Asherson R, Weinberger A, Kinsley R: Radial artery occlusion in primary antiphospholipid syndrome after aortic valve replacement. S Afr Med J. 1995, 85: 1042-","journal-title":"S Afr Med J"},{"key":"333_CR96","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S1053-0770(97)90173-7","volume":"11","author":"F Sheikh","year":"1997","unstructured":"Sheikh F, Lechowicz A, Selut R, Rauch A, Dunn H: Recognition and management of patients with antiphospholipid antibody syndrome undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 1997, 11: 764-6. 10.1016\/S1053-0770(97)90173-7.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"333_CR97","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/S0003-4975(98)00910-2","volume":"66","author":"M Ando","year":"1998","unstructured":"Ando M, Takamoto S, Okita Y: Operation for chronic pulmonary thromboembolism accompanied by thrombophilia in 8 patients. Ann Thorac Surg. 1998, 66: 1919-24. 10.1016\/S0003-4975(98)00910-2.","journal-title":"Ann Thorac Surg"},{"key":"333_CR98","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S1053-0770(97)90125-7","volume":"11","author":"AR Ducart","year":"1997","unstructured":"Ducart AR, Collard EL, Osselaer JC, Broka SM, Eucher PM, Joucken KL: Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant. J Cardiothorac Vasc Anesth. 1997, 11: 878-9. 10.1016\/S1053-0770(97)90125-7.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"333_CR99","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejcts.2009.06.046","volume":"37","author":"A Colli","year":"2010","unstructured":"Colli A, Mestres CA, Espinosa G, Plas\u00edn MA, Pomar JL, Font J, Cervera R: Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases. Eur J Cardiothorac Surg. 2010, 37 (1): 154-8. 10.1016\/j.ejcts.2009.06.046.","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1749-8090-5-101\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1749-8090-5-101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1749-8090-5-101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1749-8090-5-101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T13:52:10Z","timestamp":1592056330000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/1749-8090-5-101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,3]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1186\/1749-8090-5-101","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,3]]},"article-number":"101"}}